CREATE: Cross-tumoral Phase 2 With Crizotinib
Conditions
- Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
- Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor
- Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1
- Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma
- Locally Advanced and/or Metastatic Clear Cell Sarcoma
- Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma
Interventions
- DRUG: Crizotinib (PF-02341066)
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators